Media Contact:
Tara DiMilia, 908-947-0500,

Portola Valley, CA – Bay Area Lyme Foundation announced today that Carin M. Rollins has joined the executive board.  She brings with her an extensive background in biotechnology and an in-depth understanding of the field of Lyme disease.

“Carin’s expertise in biotechnology and commitment to our cause will be a significant force in helping us reach our goal of making Lyme disease easy to diagnose and simple to cure.” said Bonnie Crater, founder and vice president of the executive board and chairman of the science committee. “We are so pleased to have Carin on our team working to find novel solutions for Lyme.”

Ms. Rollins’ experience includes biotechnology equity research, management consulting and venture capital for Robertson Stephens & Company, Booz Allen & Hamilton, Bay City Capital and 5AM Ventures.  She has also been involved with several Lyme disease research efforts and helped spearhead the Lyme diagnostics workshop at the National Institutes of Standards and Technology (NIST).  She has served on the Board of Directors of a number of biotech companies and organizations and currently manages CR Consulting, LLC, which provides consulting services to the biotech sector.  Ms. Rollins holds an MBA from Stanford Graduate School of Business and a BA in Biology from Colgate University.

“I am excited by the opportunity to use the tools I have learned throughout my biotechnology career to benefit people, including friends and family, affected by the debilitating symptoms of Lyme,” says Rollins. “The Bay Area Lyme Foundation is engaging an incredible network and is poised to make a major impact in the field.  I am thrilled to be a part of it.”

About Bay Area Lyme Foundation

Bay Area Lyme Foundation is committed to making Lyme disease easy to diagnose and simple to cure.  A national 501(c)3 non-profit organization, the Foundation collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease. It is also dedicated to providing reliable, fact-based information so that prevention and the importance of early treatment is common knowledge.   For more information on Lyme disease or to get involved, visit or call us, 650-530-2439.



Leave a Comment

Your email address will not be published. Required fields are marked *